Gerd Bode
University of Gottingen, Germany
Biography
Gerd Bode, holds board certified specializations in Pathology, Neuropathology, Legal Medicine, Pharmacology and Toxicology. After his university career he was head for Drug Safety and Pharmacovigilance at Boehringer Mannheim (Germany), then head of Lead Optimisation (Pharmacology, Toxicology, Kinetics, Metabolism and Clinical Phase I) at Hoechst Marion Roussel/Aventis (Paris/France). And finally head of preclinical research and development of ALTANA Pharma AG, Germany (Hamburg) until 2005. He serves as lecturer at several German, Swiss and French universities. He was for the European Industry (EFPIA) ICH-Topic Leader for Preclinical Safety Guidelines from 1989 to 2005 in the International Conferences on Harmonisation. He works now as a lecturer and independent consultant.
Abstract
Abstract : Change of rodent carcinogenicity testing